Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionRZG - Invesco S&P SmallCap 600 Pure Growth ETF
Latest Disclosed Ownership41,231 shares
Latest Disclosed Value $ 1,159,828
RZG - Invesco S&P SmallCap 600 Pure Growth ETF reports 0.25% increase in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On June 26, 2026 - RZG - Invesco S&P SmallCap 600 Pure Growth ETF filed a NPORT-P form disclosing ownership of 41,231 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $1,159,828 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 30, 2026 disclosing 41,127 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 0.25% during the quarter. The current value of the position is $1,298,364 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-26 2026-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 41,231 104 0.25 1,160 16.02 0.9522
2026-03-30 2026-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 41,127 -6,819 -14.22 999 -1.96 0.9121
2025-12-29 2025-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 47,946 -1,642 -3.31 1,020 -3.60 0.9819
2025-09-29 2025-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 49,588 -5,458 -9.92 1,058 -20.94 1.0715
2025-06-27 2025-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 55,046 -1,250 -2.22 1,337 5.28 1.3556
2025-03-28 2025-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 56,296 16,894 42.88 1,270 48.02 1.1264
2024-12-27 2024-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 39,402 -4,793 -10.85 859 12.75 0.8055
2024-09-27 2024-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 44,195 4,859 12.35 762 28.55 0.6232
2024-06-26 2024-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 39,336 462 1.19 592 5.90 0.5985
2024-03-28 2024-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 38,874 -39,663 -50.50 560 -42.61 0.5781
2023-12-28 2023-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 78,537 1,911 2.49 975 -8.03 1.1665
2023-09-28 2023-07-31 NP Catalyst Pharmaceuticals EC US14888U1016 76,626 -1,500 -1.92 1,060 -14.80 1.0649
2023-06-29 2023-04-30 NP Catalyst Pharmaceuticals EC US14888U1016 78,126 -2,666 -3.30 1,244 -0.64 1.4206
2023-04-03 2023-01-31 NP Catalyst Pharmaceuticals EC US14888U1016 80,792 -14,434 -15.16 1,251 -5.23 1.3114
2022-12-28 2022-10-31 NP Catalyst Pharmaceuticals EC US14888U1016 95,226 95,226 1,321 1.2621
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.